SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

JP Morgan Maintains Neutral on Mednax, Lowers Price Target to $26

JP Morgan maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $29 to $26.

Benzinga · -

JP Morgan maintains Mednax (NYSE:MD) with a Neutral and lowers the price target from $29 to $26.